ACHV · Achieve Life Sciences Inc
United States · RS rating 91 · As of 2026-10-14
| Price | 7.00 USD |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 91 / 40 / 90 / 96 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 39 / 47 / 44 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +0.0% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +17.9% |
| Market cap (USD) | $220.9M |